De Pardieu has advised the banks on the financing of the LBO relating to the Coravia Group, involving the acquisition of an equity stake by NextStage AM and Innovafonds. The transaction financing amounts to €25 million.
Founded in 2016 by Alexandre Bataille, the Coravia Group has grown through successive acquisitions, building an integrated offering of medical devices and technological solutions dedicated to risk prevention, safer care pathways and support for individuals experiencing loss of autonomy. Its offering notably includes Podowell, Oreus, CRMS and Telegrafik.
The transaction is intended to support the organic growth of the Coravia Group and the continued implementation of its external growth strategy in France and across Europe. It also includes the acquisition of Medissimo, a specialist in the preparation of unit-dose medication, further strengthening the group’s offering to nursing homes and in the home care sector.
As part of the transaction, NextStage AM is acquiring a minority stake in the Coravia Group through its FPCI NextStage Championnes IV fund, representing an investment of €19 million. Innovafonds is also participating in the transaction, while Aquiti, Siparex Entrepreneur and UI Investissement are selling their respective stakes.
The Coravia Group was advised by Advéo Avocats.